{"name": "Glycominds",
 "permalink": "glycominds",
 "crunchbase_url": "http://www.crunchbase.com/company/glycominds",
 "homepage_url": "http://www.glycominds.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "",
 "phone_number": "972-8-9181080",
 "description": "",
 "created_at": "Fri Sep 03 10:25:08 UTC 2010",
 "updated_at": "Fri Sep 03 10:33:11 UTC 2010",
 "overview": "\u003Cp\u003EGlycominds, a molecular diagnostics company, develops and commercializes autoimmune and chronic inflammatory disease management tools and services with a distinctive focus on the Multiple Sclerosis market. Their proprietary tests allow physicians to help identify patients at a higher risk for more severe disease outcomes. \u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       41],
      "assets/images/resized/0010/0445/100445v1-max-150x150.jpg"],
     [[210,
       58],
      "assets/images/resized/0010/0445/100445v1-max-250x250.jpg"],
     [[210,
       58],
      "assets/images/resized/0010/0445/100445v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$1M",
 "funding_rounds":
  [{"round_code": "unattributed",
    "source_url": "",
    "source_description": "EDGAR",
    "raised_amount": 1000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2005,
    "funded_month": null,
    "funded_day": null,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "BRM Capital",
         "permalink": "brm-capital",
         "image":
          {"available_sizes":
            [[[140,
               94],
              "assets/images/resized/0001/5437/15437v2-max-150x150.png"],
             [[140,
               94],
              "assets/images/resized/0001/5437/15437v2-max-250x250.png"],
             [[140,
               94],
              "assets/images/resized/0001/5437/15437v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Millennium II Materials Technology Fund",
         "permalink": "millennium-ii-materials-technology-fund",
         "image":
          {"available_sizes":
            [[[150,
               32],
              "assets/images/resized/0004/9799/49799v1-max-150x150.png"],
             [[250,
               54],
              "assets/images/resized/0004/9799/49799v1-max-250x250.png"],
             [[270,
               59],
              "assets/images/resized/0004/9799/49799v1-max-450x450.png"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "1 Yodfat St.,",
    "address2": "Alon Building, Global Park",
    "zip_code": "71291",
    "city": "Lod",
    "state_code": null,
    "country_code": "ISR",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        88],
       "assets/images/resized/0010/0446/100446v1-max-150x150.jpg"],
      [[250,
        146],
       "assets/images/resized/0010/0446/100446v1-max-250x250.jpg"],
      [[450,
        264],
       "assets/images/resized/0010/0446/100446v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}